John Mellem
Overview
Explore the profile of John Mellem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elamin G, Zhang Z, Dwarka D, Kasumbwe K, Mellem J, Mkhwanazi N, et al.
Front Genet
. 2025 Jan;
15:1502152.
PMID: 39840282
Objectives: Unlike other diseases, cancer is not just a genome disease but should broadly be viewed as a disease of the cellular machinery. Therefore, integrative multifaceted approaches are crucial to...
2.
Naicker S, Mohanlall V, Ngubane S, Mellem J, Mchunu N
J Fungi (Basel)
. 2023 Jun;
9(6).
PMID: 37367552
The rapid emergence of invasive fungal infections correlates with the increasing population of immunocompromised individuals, with many cases leading to death. The progressive increase in the incidence of isolates is...
3.
Adu O, Naidoo Y, Lin J, Dwarka D, Mellem J, Murthy H, et al.
Plants (Basel)
. 2023 Feb;
12(4).
PMID: 36840116
is traditionally used for an anti-bacterial property. Its cytotoxic effects have not been studied before. Therefore, this study aimed to examine the nutritional properties as well the cytotoxic effects of...
4.
Naiker T, Gerrano A, Mellem J
J Food Sci Technol
. 2019 Apr;
56(3):1541-1550.
PMID: 30956334
The variability and magnitude of interactions for food components and physicochemical properties of flour produced from five cultivars of cowpea (, , , , ) were analysed using chemometrical techniques,...
5.
Odun-Ayo F, Mellem J, Naicker T, Reddy L
Anticancer Res
. 2015 Aug;
35(9):4765-75.
PMID: 26254367
Background: Increased intake of probiotic dietary fibre reduces colonic cancer risk. Modified citrus pectin (MCP) requires optimal bioactivity to inhibit galectin-3 (GAL-3) and vascular endothelial growth factor (VEGF). This study...